These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8735304)

  • 21. Surveillance for endometrial cancer in women receiving tamoxifen.
    Suh-Burgmann EJ; Goodman A
    Ann Intern Med; 1999 Jul; 131(2):127-35. PubMed ID: 10419429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
    Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks and benefits of tamoxifen therapy.
    Assikis VJ; Jordan VC
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):21-3. PubMed ID: 9065923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should women receiving tamoxifen be screened for endometrial cancer? An argument for screening.
    Menzin AW; Gal D; Barakat RR
    Cancer Invest; 2000; 18(8):793-7. PubMed ID: 11107449
    [No Abstract]   [Full Text] [Related]  

  • 26. Postmenopausal HRT--a role for a safe antioestrogen.
    Williams GM
    Int J Clin Pract; 1998; 52(1):5. PubMed ID: 9536558
    [No Abstract]   [Full Text] [Related]  

  • 27. Committee Opinion No. 601: Tamoxifen and uterine cancer.
    Obstet Gynecol; 2014 Jun; 123(6):1394-1397. PubMed ID: 24848920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen and menopausal status: risks and benefits.
    Sasco AJ
    Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of endometrial cancer in breast cancer patients under long-term adjuvant treatment with tamoxifen.
    Cecchini S; Ciatto S; Bonardi R; Mazzotta A; Pacini P; Muraca MG; Zappa M
    Tumori; 1998; 84(1):21-3. PubMed ID: 9619708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen. 'A big deal,' but a complex hand to play.
    Marshall E
    Science; 1998 Apr; 280(5361):196. PubMed ID: 9565527
    [No Abstract]   [Full Text] [Related]  

  • 31. Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
    Fisher B
    J Clin Oncol; 1996 Mar; 14(3):1027-39. PubMed ID: 8622007
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
    Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
    Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial metastasis from breast cancer in a patient receiving tamoxifen therapy.
    Horn LC; Einenkel J; Baier D
    Gynecol Obstet Invest; 2000; 50(2):136-8. PubMed ID: 10965200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective estrogen-receptor modulators in 2001.
    O'Regan RM; Gradishar WJ
    Oncology (Williston Park); 2001 Sep; 15(9):1177-85, 1189-90; discussion 1190-4. PubMed ID: 11589065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tamoxifen and endometrial cancer].
    Salamanca-Gómez F
    Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554
    [No Abstract]   [Full Text] [Related]  

  • 36. The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer.
    Overmoyer BA
    Cleve Clin J Med; 1999 Jan; 66(1):33-40. PubMed ID: 9926629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
    Hann LE; Gretz EM; Bach AM; Francis SM
    AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversy about uterine effects and safety of SERMs: the saga continues.
    Goldstein SR
    Menopause; 2002; 9(5):381-4. PubMed ID: 12218728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growth.
    Mäenpää J; Ellmén J; Pasanen T; Kaukonen M
    J Natl Cancer Inst; 1999 Jun; 91(11):972-3. PubMed ID: 10359551
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population-based case-control study.
    Pukkala E; Kyyrönen P; Sankila R; Holli K
    Int J Cancer; 2002 Jul; 100(3):337-41. PubMed ID: 12115550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.